ORCHID PHARMA LIMITED

Other languages Orchid Pharma Limited Bombay S.E.

Equities

ORCHPHARMA

INE191A01027

Market Closed - Bombay S.E. Other stock markets 06:00:48 2024-05-17 EDT			5-day change	1st Jan Change
1,091 ^INR	+1.05%		+7.62%	+52.80%

04-12	Orchid Pharma Limited Announces Resignation of Mudit Tandon as Independent Director	CI
02-23	Orchid Pharma Receives United States Food and Drug Administration Approval for Its Novel Invention	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Orchid Pharma Limited Announces Resignation of Mudit Tandon as Independent Director	04-12
Orchid Pharma Receives United States Food and Drug Administration Approval for Its Novel Invention	02-23
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-08
European Medicines Agency Grants Approval for Orchid Pharma's 'Exblifep'	01-30
Orchid Pharma Limited Appoints Kapil Dayya as Company Secretary & Compliance Officer	12-16
Orchid Pharma Limited Announces Resignation of Marina Peter as Company Secretary and Compliance Officer	12-14
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-04
Orchid Pharma Limited Approves the Appointment of Mr. Arjun Dhanuka as Additional Director (In Capacity of Non-Executive & Non-Independent)	23-10-20
Orchid Pharma Limited Enters into Manufacturing Sub License Agreement with Global Antibiotic Research & Development Partnership	23-09-12
Orchid Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10
Orchid Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-10
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-09
Orchid Pharma Limited Announces Demise of Arun Kumar Dhanuka, Non-Executive & Non-Independent Director	23-02-01
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW